Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.

The Prostate(2023)

引用 0|浏览14
暂无评分
摘要
A low pretreatment PNI might be an effective biomarker of poor treatment response and survival in patients with mHSPC undergoing ADT.
更多
查看译文
关键词
androgen deprivation therapy, metastatic hormone-sensitive prostate cancer, prognostic nutritional index, prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要